Inventor · disambiguated record
Joseph K. Belanoff
Also filed as: BELANOFF JOSEPH · BELANOFF JOSEPH K
38 granted patents·27 pending applications·338 citations·filing 1999–2025
98Inventor score
Files withCORCEPT THERAPEUTICS INC52BELANOFF JOSEPH K5UNIV LELAND STANFORD JUNIOR3BELANOFF JOSEPH1Corcept Therapeutics1
Top patents by PatentIndex Score
65 records- 0195US11890289B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2021·Granted Feb 6, 2024·4 cites·9 claims
- 0295US11202784B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2020·Granted Dec 21, 2021·5 cites·11 claims
- 0395US10881660B2Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jan 5, 2021·9 cites·23 claims
- 0495US9943526B2Optimizing mifepristone levels for cushing's patientsCORCEPT THERAPEUTICS INC·Filed 2016·Granted Apr 17, 2018·12 cites·9 claims
- 0595US8598149B2Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonistsBELANOFF JOSEPH K·Filed 2008·Granted Dec 3, 2013·17 cites·7 claims
- 0693US8921348B2Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonistsCorcept Therapeutics·Filed 2013·Granted Dec 30, 2014·17 cites·7 claims
- 0792US10238659B2Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2015·Granted Mar 26, 2019·13 cites·14 claims
- 0891US10195214B2Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitorsCORCEPT THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·6 cites·13 claims
- 0991US10166243B1Optimizing mifepristone levels for cushing'S patientsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Jan 1, 2019·3 cites·20 claims
- 1091US6680310B2Methods for preventing antipsychotic-induced weight gainCORCEPT THERAPEUTICS INC·Filed 2002·Granted Jan 20, 2004·45 cites·15 claims
- 1190US10842800B2Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitorsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Nov 24, 2020·5 cites·14 claims
- 1290US10166242B2Optimizing mifepristone levels for Cushing's patientsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Jan 1, 2019·3 cites·9 claims
- 1389US12109272B2Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancersCORCEPT THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·1 cites·14 claims
- 1489US11268145B2Methods for treating Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·3 cites·2 claims
- 1589US7361646B2Methods for treating gastroesophageal reflux diseaseCORCEPT THERAPEUTICS INC·Filed 2003·Granted Apr 22, 2008·29 cites·14 claims
- 1689US2024358718A1Concomitant administration of glucocorticoid receptor modulators and cyp3a inhibitorsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1788US12097210B2Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitorsCORCEPT THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·0 cites·20 claims
- 1888US10604807B2Methods for diagnosing and assessing treatment for Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2016·Granted Mar 31, 2020·3 cites·5 claims
- 1986US11590135B2Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·1 cites·20 claims
- 2086US10610534B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2016·Granted Apr 7, 2020·2 cites·9 claims
- 2185US6620802B1Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonistCORCEPT THERAPEUTICS INC·Filed 2000·Granted Sep 16, 2003·20 cites·13 claims
- 2284US10660904B2Optimizing mifepristone levels for cushing's patientsCORCEPT THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·1 cites·20 claims
- 2383US11103514B2Treatment of muscular dystrophyBELANOFF JOSEPH·Filed 2011·Granted Aug 31, 2021·5 cites·12 claims
- 2483US6964953B2Methods for treating stress disorders using glucocorticoid receptor-specific antagonistsCORCEPT THERAPEUTICS INC·Filed 2002·Granted Nov 15, 2005·16 cites·16 claims
- 2582US12226417B2Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2023·Granted Feb 18, 2025·0 cites·20 claims
- 2682US6150349AMethods for treating psychosis associated with glucocorticoid related dysfunctionUNIV LELAND STANFORD JUNIOR·Filed 1999·Granted Nov 21, 2000·46 cites·13 claims
- 2781US11969435B2Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Apr 30, 2024·0 cites·17 claims
- 2881US6362173B1Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonistsUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Mar 26, 2002·13 cites·12 claims
- 2981US2024156835A1Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3080US7163934B2Methods for treating delirium glucocorticoid receptor-specific antagonistsCORCEPT THERAPEUTICS INC·Filed 2002·Granted Jan 16, 2007·7 cites·11 claims
- 3178US8097606B2Antiglucocorticoids for the treatment of catatoniaBELANOFF JOSEPH K·Filed 2004·Granted Jan 17, 2012·7 cites·9 claims
- 3276US7402578B2Methods for inhibiting cognitive deterioration in adults with down's syndromeCORCEPT THERAPEUTICS INC·Filed 2002·Granted Jul 22, 2008·8 cites·15 claims
- 3375US7326697B2Methods for increasing the therapeutic response to electroconvulsive therapyCORCEPT THERAPEUTICS INC·Filed 2003·Granted Feb 5, 2008·8 cites·22 claims
- 3474US2025041432A1Intermittent Dosing of Glucocorticoid Receptor Modulators for the Treatment of Ovarian and Other CancersCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3572US11173165B2Optimizing mifepristone levels for Cushing's patientsCORCEPT THERAPEUTICS INC·Filed 2020·Granted Nov 16, 2021·0 cites·15 claims
- 3672US2025221995A1Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3770US8476254B2Methods for treating psychosis associated with interferson-α therapyBELANOFF JOSEPH K·Filed 2003·Granted Jul 2, 2013·4 cites·19 claims
- 3868US6369046B1Methods for treating dementiaUNIV LELAND STANFORD JUNIOR·Filed 1999·Granted Apr 9, 2002·24 cites·20 claims
- 3967US7884091B2Methods for treating delirium using glucocorticoid receptor-specific antagonistsCORCEPT THERAPEUTICS INC·Filed 2006·Granted Feb 8, 2011·0 cites·7 claims
- 4067US2021128584A1Use of glucocorticoid receptor antagonists for the treatment of amyotrophic lateral sclerosisCORCEPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4166US2024075030A1Methods For Reducing Liver Fat and For Treating Fatty Liver DisordersCORCEPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4266US2024261287A1Methods of treating antipsychotic-induced weight gain with miricorilantCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4365US2011166115A1Use of mifepristone for the treatment of amyotrophic lateral sclerosisCORCEPT THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 4465US2005080061A1Antiglucocorticoid therapy for the prevention of neurological damage in premature infantsCORCEPT THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 4564US2025360125A1Methods and compositions for treating huntington's disease and its symptomsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4664US2020147107A1Concomitant administration of glucocorticoid receptor modulators and cyp3a inhibitorsCORCEPT THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4763US8450379B2Methods for treating migraineBELANOFF JOSEPH K·Filed 2003·Granted May 28, 2013·1 cites·8 claims
- 4863US2009029959A1Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature InfantsCORCEPT THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 4963US2020216905A1Methods for diagnosing and assessing treatment for cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5062US8741880B2Antiglucocorticoid therapy for the prevention of neurological damage in premature infantsBELANOFF JOSEPH K·Filed 2011·Granted Jun 3, 2014·0 cites·15 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph K. Belanoff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →